Laura Hargrove

1.2k total citations
30 papers, 798 citations indexed

About

Laura Hargrove is a scholar working on Immunology, Hepatology and Oncology. According to data from OpenAlex, Laura Hargrove has authored 30 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Hepatology and 9 papers in Oncology. Recurrent topics in Laura Hargrove's work include Mast cells and histamine (11 papers), Liver physiology and pathology (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). Laura Hargrove is often cited by papers focused on Mast cells and histamine (11 papers), Liver physiology and pathology (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). Laura Hargrove collaborates with scholars based in United States, Italy and Japan. Laura Hargrove's co-authors include Lindsey Kennedy, Jennifer Demieville, Gianfranco Alpini, Heather Francis, Heather Francis, Fanyin Meng, Sharon DeMorrow, Taylor Francis, Konstantina Kyritsi and John F. Greene and has published in prestigious journals such as Gastroenterology, Hepatology and The FASEB Journal.

In The Last Decade

Laura Hargrove

29 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Hargrove United States 18 271 252 246 226 192 30 798
Kahini A. Vaid United States 10 402 1.5× 339 1.3× 183 0.7× 122 0.5× 297 1.5× 15 869
Christian Cahlin Sweden 19 317 1.2× 189 0.8× 287 1.2× 92 0.4× 199 1.0× 35 1.1k
Emma L. Shepherd United Kingdom 14 221 0.8× 159 0.6× 94 0.4× 66 0.3× 154 0.8× 24 630
Shinya Sakurai Japan 16 262 1.0× 157 0.6× 64 0.3× 127 0.6× 231 1.2× 31 710
Takahiro Nishio Japan 15 344 1.3× 392 1.6× 236 1.0× 74 0.3× 169 0.9× 66 796
Núria Tarrats United Kingdom 12 224 0.8× 158 0.6× 99 0.4× 133 0.6× 337 1.8× 13 763
Varinder Athwal United Kingdom 13 251 0.9× 224 0.9× 135 0.5× 45 0.2× 254 1.3× 35 785
Lidia Tihaa Germany 12 224 0.8× 217 0.9× 99 0.4× 95 0.4× 322 1.7× 14 695
Giammarco Fava Italy 23 287 1.1× 543 2.2× 771 3.1× 93 0.4× 276 1.4× 38 1.4k
Daniel Rodrigo‐Torres Spain 14 629 2.3× 565 2.2× 309 1.3× 97 0.4× 334 1.7× 21 1.2k

Countries citing papers authored by Laura Hargrove

Since Specialization
Citations

This map shows the geographic impact of Laura Hargrove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Hargrove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Hargrove more than expected).

Fields of papers citing papers by Laura Hargrove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Hargrove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Hargrove. The network helps show where Laura Hargrove may publish in the future.

Co-authorship network of co-authors of Laura Hargrove

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Hargrove. A scholar is included among the top collaborators of Laura Hargrove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Hargrove. Laura Hargrove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, Lindsey, Vik Meadows, Konstantina Kyritsi, et al.. (2020). Amelioration of Large Bile Duct Damage by Histamine-2 Receptor Vivo-Morpholino Treatment. American Journal Of Pathology. 190(5). 1018–1029. 13 indexed citations
2.
Kennedy, Lindsey, Vik Meadows, Jennifer Demieville, et al.. (2020). Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling. Laboratory Investigation. 100(6). 837–848. 20 indexed citations
3.
Meadows, Vik, Lindsey Kennedy, Laura Hargrove, et al.. (2019). Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2−/− mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(12). 165557–165557. 30 indexed citations
4.
Meng, Fanyin, Lindsey Kennedy, Laura Hargrove, et al.. (2018). Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2−/− mice and human primary sclerosing cholangitis. Laboratory Investigation. 98(11). 1465–1477. 33 indexed citations
5.
Kennedy, Lindsey, et al.. (2017). Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights. Gene Expression. 18(1). 5–17. 94 indexed citations
6.
Hargrove, Laura, et al.. (2017). Cellular crosstalk during cholestatic liver injury. Liver Research. 1(1). 26–33. 15 indexed citations
7.
Kennedy, Lindsey, Laura Hargrove, Jennifer Demieville, et al.. (2017). Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling. American Journal Of Pathology. 188(3). 600–615. 27 indexed citations
8.
Hargrove, Laura, et al.. (2017). Commonly Used H1 and H2 Histamine Receptor (HR) Blockers Decrease Cholangiocarcinoma Xenograft Tumor Growth, Angiogenesis and EMT. Gastroenterology. 152(5). S1182–S1183. 1 indexed citations
9.
Jones, Hannah, Laura Hargrove, Lindsey Kennedy, et al.. (2016). Inhibition of mast cell‐secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2−/− mice. Hepatology. 64(4). 1202–1216. 69 indexed citations
10.
Hargrove, Laura, et al.. (2016). Isolation and characterization of hepatic mast cells from cholestatic rats. Laboratory Investigation. 96(11). 1198–1210. 21 indexed citations
11.
Kennedy, Lindsey, Fanyin Meng, Julie Venter, et al.. (2016). Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice. Laboratory Investigation. 96(12). 1256–1267. 42 indexed citations
12.
Johnson, Christopher M., Victoria Huynh, Laura Hargrove, et al.. (2015). Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor–Dependent Signaling. American Journal Of Pathology. 186(1). 123–133. 57 indexed citations
13.
Francis, Heather & Laura Hargrove. (2015). Knockout of Histidine Decarboxylase (HDC) Reduces Hepatic Fibrosis in Bile Duct Ligated (BDL) Mice. The FASEB Journal. 29(S1). 1 indexed citations
14.
Venter, Julie, Heather Francis, Fanyin Meng, et al.. (2015). Development and functional characterization of extrahepatic cholangiocyte lines from normal rats. Digestive and Liver Disease. 47(11). 964–972. 9 indexed citations
15.
Meng, Fanyin, Sharon DeMorrow, Julie Venter, et al.. (2014). Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth. American Journal of Physiology-Gastrointestinal and Liver Physiology. 306(9). G759–G768. 25 indexed citations
16.
Hargrove, Laura, Taylor Francis, & Heather Francis. (2014). Vitamin D and GI cancers: shedding some light on dark diseases.. PubMed. 2(1). 9–9. 19 indexed citations
17.
Johnson, Christopher M., Laura Hargrove, Lindsey Kennedy, et al.. (2014). Histamine restores biliary mass following carbon tetrachloride-induced damage in a cholestatic rat model. Digestive and Liver Disease. 47(3). 211–217. 6 indexed citations
18.
Kennedy, Lindsey, Laura Hargrove, Taylor Francis, et al.. (2014). Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents. Laboratory Investigation. 94(12). 1406–1418. 44 indexed citations
19.
Hargrove, Laura, et al.. (2013). 367 Mast Cell Histamine Participates in the Paracrine Regulation of Cholangiocyte Proliferation. Gastroenterology. 144(5). S–943.
20.
Kennedy, Lindsey, Julie Venter, Laura Hargrove, et al.. (2013). Dysregulation of vitamin D3 synthesis leads to enhanced cholangiocarcinoma growth. Digestive and Liver Disease. 45(4). 316–322. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kahini A. Vaid Breakdown of academic impact, for papers by Christian Cahlin Breakdown of academic impact, for papers by Emma L. Shepherd Breakdown of academic impact, for papers by Shinya Sakurai Breakdown of academic impact, for papers by Takahiro Nishio Breakdown of academic impact, for papers by Núria Tarrats Breakdown of academic impact, for papers by Varinder Athwal Breakdown of academic impact, for papers by Lidia Tihaa Breakdown of academic impact, for papers by Giammarco Fava Breakdown of academic impact, for papers by Daniel Rodrigo‐Torres
Rankless by CCL
2026